Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Liposomal doxorubicin with and without TNFalpha in the perfusional treatment of advanced soft tissue limb sarcoma: preliminary results.
Di Filippo F, Anzà M, Garinei R, Cavaliere F, Perri P, Botti C, Di Angelo P, Di Filippo S, Maini CL, Pasqualoni R, Di Segni S, Colantonio S, Bruno P, Piarulli L, Principi F. Di Filippo F, et al. Among authors: di segni s, di filippo s, di angelo p. In Vivo. 2006 Nov-Dec;20(6A):735-8. In Vivo. 2006. PMID: 17203757 Free article. Clinical Trial.
Old age: biologic versus chronologic.
Gelibter AJ, Di Segni S, Zeuli M, Milella M, Ferretti G, Nuzzo C, Cognetti F. Gelibter AJ, et al. Among authors: di segni s. J Clin Oncol. 2007 Feb 20;25(6):e8. doi: 10.1200/JCO.2006.09.6917. J Clin Oncol. 2007. PMID: 17308262 No abstract available.
Bevacizumab: one treatment for all the seasons?
Gelibter AJ, Di Segni S, Zeuli M, Cognetti F. Gelibter AJ, et al. Among authors: di segni s. J Clin Oncol. 2008 Jan 20;26(3):511; author reply 511-2. doi: 10.1200/JCO.2007.15.0292. J Clin Oncol. 2008. PMID: 18202430 No abstract available.
Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA).
Breccia M, Celant S, Olimpieri PP, Olimpieri OM, Pane F, Iurlo A, Cirilli A, Colatrella A, Gozzo L, Pugliese S, Summa V, Foggi P, Corradini P, Russo P; AIFA Monitoring Registries Group. Breccia M, et al. Ann Hematol. 2021 Feb;100(2):481-485. doi: 10.1007/s00277-021-04406-1. Epub 2021 Jan 7. Ann Hematol. 2021. PMID: 33415425
Withdrawal notice to <Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]>
Iacovino ML, Celant S, Tomassini L, Arenare L, Caglio A, Canciello A, Salerno F, Olimpieri PP, Di Segni S, Sferrazza A, Piccirillo MC, Beretta GD, Pinto C, Blasi L, Cinieri S, Cavanna L, Di Maio M, Russo P, Perrone F. Iacovino ML, et al. Among authors: di segni s. Lancet Reg Health Eur. 2024 Sep 2;44:101012. doi: 10.1016/j.lanepe.2024.101012. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39444700 Free PMC article.
16 results